MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$9,763K
Free Cash flow
-$44,201K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Proceeds from long-term debt, ne...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-59,532
-63,504
-60,531
-62,321
Depreciation and amortization
90
89
89
87
Stock-based compensation
13,948
11,946
10,043
9,514
Amortization/accretion of investment securities
489
1,069
1,632
1,739
Loss from initial consolidation of variable interest entity
0
-
0
0
Non-cash lease expense
133
129
124
120
Non-cash interest expense
221
206
211
211
Other non-cash items
2
12
-1
0
Prepaid expenses and other current assets
-2,282
4,546
1,382
-371
Accounts payable
-4,919
2,741
1,750
918
Accrued external research and development expenses
2,187
686
3,746
242
Other accrued expenses
2,054
-8,734
4,446
4,954
Operating lease liabilities
-174
-168
-165
-156
Net cash used in operating activities
-44,201
-62,236
-43,300
-47,799
Purchases of marketable securities
92,731
93,762
358,273
85,436
Maturities of marketable securities
114,360
152,069
135,400
135,000
Purchases of property and equipment
0
0
20
26
Net cash provided by (used in) investing activities
21,629
58,307
-222,893
49,538
Proceeds from sale of common stock in underwritten offering, net of issuance costs paid
0
0
206,343
0
Proceeds from sale of pre-funded warrants in underwritten offering, net of issuance costs paid
0
0
4,690
0
Proceeds from sale of common stock in at-the-market offerings, net of issuance costs paid
-
-
0
9,766
Proceeds from long-term debt, net of issuance costs paid
29,979
-
0
-
Payment of debt issuance costs
-
-
0
-
Proceeds from stock option exercises
2,356
1,010
5,643
1,531
Contributions from employee stock purchase plan
0
687
0
291
Net cash provided by financing activities
32,335
1,697
216,676
11,588
Net increase (decrease) in cash, cash equivalents and restricted cash
9,763
-2,232
-49,517
13,327
Cash, cash equivalents and restricted cash, beginning of period
89,155
91,387
140,904
192,672
Cash, cash equivalents and restricted cash, end of period
98,918
89,155
91,387
140,904
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from long-term
debt, net of issuance...
$29,979K
Proceeds from stock
option exercises
$2,356K
(60.60%↑ Y/Y)
Maturities of marketable
securities
$114,360K
(-38.46%↓ Y/Y)
Net cash provided by
financing activities
$32,335K
(-86.81%↓ Y/Y)
Net cash provided by
(used in) investing...
$21,629K
(109.79%↑ Y/Y)
Canceled cashflow
$92,731K
Net increase
(decrease) in cash, cash...
$9,763K
(115.00%↑ Y/Y)
Canceled cashflow
$44,201K
Stock-based compensation
$13,948K
(-5.65%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,282K
(-128.85%↓ Y/Y)
Accrued external
research and development...
$2,187K
(579.19%↑ Y/Y)
Other accrued
expenses
$2,054K
(181.57%↑ Y/Y)
Non-cash interest
expense
$221K
(-46.75%↓ Y/Y)
Non-cash lease expense
$133K
(-41.92%↓ Y/Y)
Depreciation and
amortization
$90K
(-14.29%↓ Y/Y)
Purchases of marketable
securities
$92,731K
(-77.15%↓ Y/Y)
Net cash used in
operating activities
-$44,201K
(50.50%↑ Y/Y)
Canceled cashflow
$20,915K
Net loss
-$59,532K
(33.36%↑ Y/Y)
Accounts payable
-$4,919K
(-207.82%↓ Y/Y)
Amortization/accretion of investment
securities
$489K
(-90.50%↓ Y/Y)
Operating lease
liabilities
-$174K
(-134.32%↓ Y/Y)
Other non-cash items
$2K
Buy us a coffee
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)